A Colon-Targeted Prodrug of Riluzole Improves Therapeutic Effectiveness and Safety upon Drug Repositioning of Riluzole to an Anti-Colitic Drug
Author:
Affiliation:
1. College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea
Funder
National Research Foundation of Korea
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.2c00255
Reference29 articles.
1. Inflammatory Bowel Disease: Etiology, Pathogenesis and Current Therapy
2. Unravelling the pathogenesis of inflammatory bowel disease
3. Treatment of inflammatory bowel disease (IBD)
4. Conventional drug therapy for inflammatory bowel disease
5. Drug repurposing: progress, challenges and recommendations
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discerning Endoscopic Severity of Inflammatory Bowel Disease by Scoping the Peripheral Blood Transcriptome;Gastro Hep Advances;2024
2. Colon-responsive oral drug delivery for combating colonic disorders;Advanced Drug Delivery Systems for Colonic Disorders;2024
3. N-Succinylaspartic-Acid-Conjugated Riluzole Is a Safe and Potent Colon-Targeted Prodrug of Riluzole against DNBS-Induced Rat Colitis;Pharmaceutics;2023-11-16
4. Colon-Targeted Trans-Cinnamic Acid Ameliorates Rat Colitis by Activating GPR109A;Pharmaceutics;2022-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3